get a key
steadybase-$ company IMUX
account_id none on file
legal_name Immunic, Inc.
ticker IMUX
cik 1280776
domain imux.com
entry_point_account_id none on file
name Immunic Inc.
exchange Nasdaq
sector Health Care
hq New York, United States
calls 0 filings 4 executives 3 family 0
why_nownone on file
callsnone on file
filings
The Company leases office space and office equipment. The underlying lease agreements have lease terms of less than 12 months and up to 60 months.

filing / Aug 11, 2026 / receipt

The Company leases certain office space under non-cancelable operating leases. The New York City office lease terminates on July 31, 2028, and the lease for the research laboratory in Planegg, Germany terminates on November 30, 2028.

filing / Aug 11, 2026 / receipt

Whaley was promoted to Chief Financial Officer. Effective January 1, 2024, Mr. Whaley's salary was increased to $445,000 and a yearly target bonus was increased to 40%.

filing / May 29, 2026 / receipt

In April 2020, he was promoted to the position of Vice President Finance, Principal Financial and Accounting Officer. In March 2022, he was promoted to the position of Chief Financial Officer.

filing / May 29, 2026 / receipt

executives
Erik Lundgren Chief Executive Officer - receipt
Patrick Walsh Chief Business Officer - receipt
Sanjay S. Patel Chief Financial Officer - receipt
familynone on file
upcoming
2026-11-12 earnings call scheduled ir
changes
2026-05-27 Chief Executive Officer, appointed sec_8k
2021-10-15 Chief Business Officer, appointed sec_8k
2019-07-17 Chief Financial Officer, appointed sec_8k
2019-07-17 Interim Chief Financial Officer, departed sec_8k
2019-04-29 Interim Chief Financial Officer, appointed sec_8k
2019-04-15 Chief Financial Officer, departed sec_8k
2019-04-15 Chief Technical Officer, departed sec_8k
2019-04-15 director, departed sec_8k
2019-04-15 President and Chief Executive Officer, departed sec_8k
mcp_package_hint
steadybase-$